Kim DW - Search Results

1

Compound mutations involving T315I and P-loop mutations are the major components of multiple mutations detected in tyrosine kinase inhibitor resistant chronic myeloid leukemia.

Kang KH, Kim SH, Choi SY, Yoo HL, Lee MY, Song HY, Kee KM, Suh JH, Yang SY, Jang EJ, Lee SE, Kim DW. Kang KH, et al. Among authors: kim dw, kim sh. Leuk Res. 2019 Jan;76:87-93. doi: 10.1016/j.leukres.2018.10.019. Epub 2018 Nov 27. Leuk Res. 2019. PMID: 30503643

2

Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations.

Kim D, Kim DW, Cho BS, Goh HG, Kim SH, Kim WS, Lee J, Kweon IY, Park SH, Yoon JH, Kim ND, Chun H. Kim D, et al. Among authors: kim dw, kim sh, kim nd, kim ws. Leuk Res. 2009 Sep;33(9):1260-5. doi: 10.1016/j.leukres.2008.12.017. Epub 2009 Feb 6. Leuk Res. 2009. PMID: 19201023

3

Sensitive quantitation of minimal residual disease in chronic myeloid leukemia using nanofluidic digital polymerase chain reaction assay.

Goh HG, Lin M, Fukushima T, Saglio G, Kim D, Choi SY, Kim SH, Lee J, Lee YS, Oh SM, Kim DW. Goh HG, et al. Among authors: kim dw, kim d, kim sh. Leuk Lymphoma. 2011 May;52(5):896-904. doi: 10.3109/10428194.2011.555569. Epub 2011 Feb 21. Leuk Lymphoma. 2011. PMID: 21338281

4

Prognostic discrimination for early chronic phase chronic myeloid leukemia in imatinib era: comparison of Sokal, Euro, and EUTOS scores in Korean population.

Yahng SA, Jang EJ, Choi SY, Lee SE, Kim SH, Kim DW. Yahng SA, et al. Among authors: kim dw, kim sh. Int J Hematol. 2014 Aug;100(2):132-40. doi: 10.1007/s12185-014-1600-4. Epub 2014 May 31. Int J Hematol. 2014. PMID: 24879034

5

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia.

Hong JH, Lee SE, Choi SY, Kim SH, Jang EJ, Bang JH, Park JE, Jeon HR, Oh YJ, Yi JE, Jung HO, Youn HJ, Kim DW. Hong JH, et al. Among authors: kim dw, kim sh. Cancer Res Treat. 2015 Oct;47(4):937-42. doi: 10.4143/crt.2013.155. Epub 2014 Nov 17. Cancer Res Treat. 2015. PMID: 25648097 Free PMC article.

6

Distinct predictive factors influence on achievement of early molecular response by frontline imatinib in chronic phase chronic myeloid leukemia.

Lee SE, Choi SY, Oh YJ, Kim SH, Song HY, Yoo HL, Lee MY, Chae MJ, Kang KH, Hwang HJ, Jang EJ, Kim DW. Lee SE, et al. Among authors: kim dw, kim sh. Leuk Res. 2015 Apr;39(4):411-8. doi: 10.1016/j.leukres.2015.01.011. Epub 2015 Jan 29. Leuk Res. 2015. PMID: 25680524

7

BCR-ABL1 transcripts (MR^4.5) at post-transplant 3 months as an early predictor for long-term outcomes in chronic myeloid leukemia.

Lee SE, Choi SY, Kim SH, Song HY, Yoo HL, Lee MY, Kang KH, Hwang HJ, Jang EJ, Kim DW. Lee SE, et al. Among authors: kim dw, kim sh. Korean J Intern Med. 2017 Jan;32(1):125-136. doi: 10.3904/kjim.2015.187. Epub 2016 Jun 22. Korean J Intern Med. 2017. PMID: 27334764 Free PMC article.

8

Baseline BCR-ABL1 transcript type of e13a2 and large spleen size are predictors of poor long-term outcomes in chronic phase chronic myeloid leukemia patients who failed to achieve an early molecular response after 3 months of imatinib therapy.

Lee SE, Choi SY, Kim SH, Song HY, Yoo HL, Lee MY, Hwang HJ, Kang KH, Kee KM, Jang EJ, Kim DW. Lee SE, et al. Among authors: kim dw, kim sh. Leuk Lymphoma. 2018 Jan;59(1):105-113. doi: 10.1080/10428194.2017.1320711. Epub 2017 May 25. Leuk Lymphoma. 2018. PMID: 28540759

9

Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib.

Lee SE, Choi SY, Kim SH, Jootar S, Kim HJ, Sohn SK, Park JS, Kim SH, Zang DY, Oh SJ, Kim DW. Lee SE, et al. Among authors: kim hj, kim dw, kim sh. Leuk Res. 2018 Jul;70:100-105. doi: 10.1016/j.leukres.2018.06.002. Epub 2018 Jun 7. Leuk Res. 2018. PMID: 29908417 Clinical Trial.

10

Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic-Phase Chronic Myeloid Leukemia.

Kim H, Kim S, Kim HJ, Kim YK, Kwak JY, Yhim HY, Kim SH, Do YR, Oh S, Lee SE, Jootar S, Cui JW, Kim DW. Kim H, et al. Among authors: kim hj, kim yk, kim dw, kim sh, kim s. Clin Lymphoma Myeloma Leuk. 2018 Oct;18(10):e391-e399. doi: 10.1016/j.clml.2018.06.031. Epub 2018 Jul 4. Clin Lymphoma Myeloma Leuk. 2018. PMID: 30082224 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,179 results

Search Page